Introduction {#S1}
============

Interventions to improve oxygen delivery and decrease oxygen consumption are the cornerstone of resuscitation in the critically ill patients and during the perioperative period of high-risk patients. Early recognition of the patients at risks and the implementation of adequate monitoring-guided interventions can have a profound effect on outcome. On the contrary, delaying adequate interventions will inevitably lead to hypoperfusion, tissue hypoxia, and multiple-organ failure affecting both outcome and wasting of resources and costs ([@B1]). Therefore, the use of appropriate indices, which are able to detect the imbalance between oxygen delivery (DO~2~) and consumption (VO~2~), is mandatory for adequate management ([@B2]). Conventional parameters such as heart rate, mean arterial blood pressure, mental status, and urine output are robust warning signs of inadequate tissue perfusion, but for fine tuning of therapy detailed hemodynamic monitoring is warranted ([@B3]). The recent FENICE (Fluid Challenges In Intensive Care) trial indicate that there is a considerable gap between the accumulating knowledge about the benefits of advanced hemodynamic monitoring based optimization and the actual clinical practice. In more than 2,000 patients, fluid challenges were evaluated. The main indicator of administering fluid boluses was hypotension in 57%, and in 43% of cases, no hemodynamic variable was used to predict fluid responsiveness ([@B4]). Detailed assessment of global hemodynamic indices such as cardiac output (CO) and derived variables and also the measures of oxygen delivery and uptake should be taken into account to provide appropriate therapy for these patients ([@B5], [@B6]). Furthermore, in addition to the optimization of global hemodynamic parameters, indicators of tissue perfusion should also be monitored to verify the effectiveness of our interventions ([@B7]). To monitor changes in tissue oxygenation, central or mixed venous blood gas measurements can give more detailed information, which should be incorporated into a multimodal approach that can lead to a better, individualized, patient-centered care. The goal of this review is to highlight the importance of central venous oxygen saturation in this multimodal, individualized hemodynamic management in the context of the pathophysiological background and the results of recent clinical and experimental studies.

Physiological Issues {#S2}
====================

Tissue oxygenation is the net product of oxygen delivery and oxygen consumption, which can be described by the following formulae ([@B8]): $$\begin{array}{l}
{\text{DO}_{2} = \text{CO} \times \text{CaO}_{2}.} \\
{\text{CaO}_{2} = \text{Hb} \times 1.34 \times \text{SaO}_{2} + 0.003 \times \text{PaO}_{2}.} \\
{\text{DO}_{2} = \text{CO} \times \left( \text{Hb} \times 1.34 \times \text{SaO}_{2} + 0.003 \times \text{PaO}_{2}\text{)}. \right.} \\
{\text{VO}_{2} = \text{CO} \times \left( \text{CaO} \right._{2} - \text{CcvO}_{2}\text{)}.} \\
{\text{VO}_{2} = \text{CO} \times \text{[(Hb} \times 1.34 \times \text{SaO}_{2} + 0.003 \times \text{PaO}_{2}\text{)}} \\
{\text{\quad\quad  } - \left( \text{Hb} \times 1.34 \times \text{ScvO}_{2} + 0.003 \times \text{PcvO}_{2} \right)\rbrack.} \\
{\text{Oxygen~extraction~}\left( {\text{O}_{2}\text{ER}} \right) = \text{VO}_{2}\text{/DO}_{2}.} \\
{\text{O}_{2}\text{ER:~}\left( {\text{SaO}_{2} - \text{ScvO}_{2}} \right)\text{/SaO}_{2}.} \\
\end{array}$$

If SaO~2~ is taken as 1, as under normal circumstances, the hemoglobin is almost fully saturated with oxygen, and the other hemodynamic variables are kept constant, then: $$\text{O}_{2}\text{ER} \approx \text{1~} - \text{~ScvO}_{2}$$

DO~2~, oxygen delivery; CO, cardiac output; Hb, hemoglobin; SaO~2~, arterial oxygen saturation; PaO~2~, partial pressure of oxygen in the arterial blood; CaO~2~, arterial oxygen content; VO~2~, oxygen consumption; ScvO~2~, central venous oxygen saturation; CcvO~2~, central venous oxygen content; O~2~ER, oxygen extraction; PcvO~2~, central venous partial pressure of oxygen.

Taking a 75-kg healthy adult man when resting, the relationship between DO~2~ and VO~2~ can be estimated as:

Oxygen delivery: $$\begin{array}{l}
{\left. \text{CO} = 70\text{ml} \times 70/\text{min} \right.\sim 5,000\text{ ml}/\text{min}.} \\
{\text{CaO}_{2} = \left( {150\text{g}/\text{l~} \times 1.34\text{ ml} \times \text{~1}.00} \right) + \left( 0.003 \times 100\text{ mmHg} \right)\sim 200\text{ ml}/l.} \\
{\left. \text{DO}_{2}\  \right.\sim\ 1,000\text{ ml}/\text{min}.} \\
\end{array}$$

Oxygen consumption: $$\begin{array}{l}
{\text{CO} = \text{70ml~} \times \text{~70/min~\textasciitilde~5,000 ml/min}.} \\
{\text{CcvO}_{2} = \left( 150\text{ g}/\text{l} \times 1\text{.34~ml} \times 0\text{.75) + (0}.003 \times 40\text{ mmHg)~\textasciitilde~150 ml/l} \right.} \\
{\text{VO}_{2} = \text{5l/min} \times \ \left( {200\text{ ml/l~} - \text{~150 ml/l}} \right)\text{~\textasciitilde~250~ml/min}.} \\
\end{array}$$

Oxygen extraction: $$\text{O}_{2}\text{ER:~250~ml/min/1,000 ml/min~} \times \text{~100} = 25\%.$$

The main difference between the equations of DO~2~ and VO~2~ is the oxygen content (CaO~2~ versus CcvO~2~), especially the central venous oxygen saturation (ScvO~2~). Therefore, it can be useful to assess the imbalance between DO~2~ and VO~2~ in the critically ill.

When the arterial oxygen content (CaO~2~) and/or CO becomes impaired, DO~2~ decreases, which is often accompanied by a parallel decrease in VO~2~. The most frequently occurring scenarios are represented in Figure [1](#F1){ref-type="fig"}. In the early phase of decreasing DO~2~, the circulation can compensate to some extent, and VO~2~ remains stable. However, beyond a critical point, any further drop in DO~2~ will result in a decrease in VO~2~. From this point, VO~2~ becomes dependent on DO~2~, and aerobic metabolism will have to be switched to anaerobic metabolism, leading to low ScvO~2~, hyperlactatemia, metabolic acidosis, and oxygen debt ([@B9]).

![Oxygen delivery and consumption in critically ill patients. DO~2~, oxygen delivery; VO~2~, oxygen consumption; ScvO~2~, central venous oxygen saturation ratio. For details, see main text.](fmed-04-00247-g001){#F1}

The principle task of early resuscitation is to regain balance by optimizing the VO~2~/DO~2~ ratio. However, it is also important to define the endpoints of resuscitation to avoid overresuscitation. In the case of fluid resuscitation, for example, unnecessary administration of fluids will lead to hypervolemia, which increases morbidity and mortality to a similar extent to that of hypovolemia ([@B10], [@B11]). Unjustified blood transfusions also carry the risk of hypervolemia and transmission of infections ([@B12]) or allergic reactions ([@B13]). There is evidence that prolonged use of catecholamines is associated with poor outcome ([@B14]). Therefore, it is important to recognize the point when tissue perfusion has been normalized, oxygen debt has been resolved, and resuscitation has been terminated.

Individualized Goal-Directed Hemodynamic Therapy {#S3}
================================================

The multimodal concept in hemodynamic monitoring enables us to appreciate that each patient is different, hence the so-called normal values, which are more or less appropriate for a given population may be inadequate for the given patient. Therefore, this concept can be translated into the individualized or personalized use of target endpoints to avoid underresuscitation or overresuscitation.

Parameters for Assessment of Tissue Metabolism {#S4}
==============================================

Mixed Venous and Central Venous Oxygen Saturation {#S4-1}
-------------------------------------------------

Mixed venous oxygen saturation (SvO~2~) measured in the pulmonary artery *via* a pulmonary artery catheter, and its surrogate, central venous oxygen saturation (ScvO~2~) measured in the superior vena cava are the most commonly used parameters to assess global oxygen extraction (VO~2~/DO~2~). As central venous catheters are frequently applied in most critically ill patients, ScvO~2~ is more readily available compared to SvO~2~. Although the absolute values of ScvO~2~ are 5% higher than SvO~2~ on average, but changes usually occur in a parallel manner ([@B15]), therefore ScvO~2~ is regarded as a surrogate marker in the clinical setting ([@B16], [@B17]).

The main factors, which influence ScvO~2~, are hemoglobin, arterial oxygen saturation of hemoglobin, CO, and oxygen consumption. There are multiple physiologic, pathophysiologic, and therapeutic factors that influence venous oxygen saturation such as anemia, hypovolemia, contractility, bleeding, sedation, fever, and pain ([@B18]).

ScvO~2~ in Intensive Care Patients {#S4-2}
----------------------------------

During sepsis, organ dysfunction is most likely the result of inadequate tissue perfusion causing cellular hypoxia. Interventions improving the balance between DO~2~ and VO~2~ may prevent the development of tissue hypoperfusion, organ dysfunction syndrome, and thus improve the outcome of septic patients. In patients with early phase of severe sepsis, septic shock, early goal-directed intervention guided by continuous monitoring of ScvO~2~, central venous pressure and mean arterial pressure (MAP), with target values of CVP 8 to 12 mmHg, MAP \> 65 mmHg and ScvO~2~ \> 70%, reduced mortality from 46.5 to 30.5% at the 28th day ([@B19]).

Although this study has been criticized for several reasons and these results could never be repeated, there is international consensus that that low ScvO~2~ values are very important warning signs of inadequate DO~2~ and can prognosticate complications and poor outcome. However, recent data suggest that high ScvO~2~ values may also have adverse outcomes in septic patients ([@B20]). Due to deranged microcirculation when shunting is present on the level of capillaries, impaired oxygen utilization can lead to normal or supraphysiological ScvO~2~ values, which represent an inability of the cells to extract oxygen in sepsis ([@B21]). In patients with ScvO~2~ \> 70% complementary blood gas parameters, such as elevated venous-to-arterial CO~2~ gap (dCO~2~) (\>6 mmHg), increased or persistently elevated serum lactate levels could help the clinicians to identify tissue hypoxia. In a retrospective analysis, septic patients with physiological ScvO~2~ and abnormal dCO~2~ mortality was significantly higher as compared to patients with normal dCO~2~ values ([@B22]).

In patients treated on intensive care units, heart failure is often present resulting impaired CO, hence decreased oxygen delivery ([@B23]), and resulting oxygen extraction imbalance that could be detected by low ScvO~2~ ([@B24]). In a clinical study after myocardial infarction in patients with heart failure and cardiogenic shock, SvO~2~ was 43%, while in patients with heart failure without shock, it was 56% compared to patients without heart failure with an SvO~2~ of 70% ([@B25]). It may also be useful in patients with cardiogenic shock requiring the support by intraaortic balloon counter pulsation. In a study during weaning period, intraaortic balloon pump assist ratio was decreased from 1:1 to 1:3. In the weaning failure group, decreased support was accompanied by a drop in ScvO~2~, while it remained constant in the successful group ([@B26]). In patients with chronic heart failure, ScvO~2~ can be chronically low. However, during acute decompensation, major cardiac events were observed in 81% of patients with ScvO~2~ ≤ 60% at 24 h after ICU admission, while it was only 13% in patients with higher ScvO~2~ ([@B27]).

ScvO~2~ and Blood Transfusion {#S4-3}
-----------------------------

In addition to heart failure, anemia is another frequent cause of impaired DO~2~ in critically ill patients, and almost 40--45% of patients will receive blood transfusion during the treatment period ([@B28]). As large multicenter trials (TRICC and TRISS) suggest that patients with hemoglobin levels above 10 mg/dl usually do not require transfusion, while red blood cell administration is usually beneficial if the hemoglobin level is below 7 mg/dl ([@B29], [@B30]). Between these values, physicians have to make decisions according to clinical signs like mental status, tachycardia, tachypnea, blood pressure, and diuresis. To be able to give additional objective data about oxygen debt of organs, ScvO~2~ may offer an easily obtainable tool to detect a low hemoglobin-related altered O~2~ER and hence may serve as a physiological trigger for blood transfusion ([@B30]). In human studies, both on volunteers and retrospective data in critically ill patients suggest that lower levels of hemoglobin compared to that of recommended by international guidelines were well tolerated and did not produce hemodynamic instability, and when oxygen imbalance occurred, it was accompanied by a significant drop in SvO~2~ ([@B30]--[@B32]). In our recent animal experiment on isovolemic anemia, we have found that anemia-induced change in VO~2~/DO~2~ showed significant correlation with changes of ScvO~2~ ([@B33]); hence, ScvO~2~ may be used as a "physiologic transfusion trigger" in otherwise hemodynamically stable patients.

ScvO~2~ and High-Risk Surgery {#S4-4}
-----------------------------

High-risk surgical patients are at an increased risk of developing imbalance between VO~2~ and DO~2~ in the perioperative period; therefore, monitoring ScvO~2~ may have a rationale during both the intraoperative and postoperative managements.

It has been shown that patients with low ScvO~2~ values preoperatively, intraoperatively, or postoperatively are at an increased risk for complications and poor prognosis ([@B34]). Therefore, it seems to be logical to maintain ScvO~2~ in normal range during the perioperative care. We reported in a small, single-center prospective randomized study about continuously measured ScvO~2~-assisted intraoperative hemodynamic optimization (CeVOX Maquet^®^ Munich Germany) during major abdominal surgery. In the conventional group, patients were treated according to mean arterial and central venous pressure, while in the ScvO~2~ group, additionally venous oxygen saturation was also measured *via* fiberoptic catheter placed in the superior vena cava. ScvO~2~ monitorization resulted in more interventions, more fluid boluses and more blood transfusion compared to the conventional group. These intervention resulted in better organ functions, less complication rate, and better 28 days of survival ([@B35]). These results are in accord with the results of an earlier single-center study, where ScvO~2~ over 73% directed group had fewer postoperative complications and had shorter length of hospital stay compared to patients in whom hemodynamic stabilization was guided according to MAP and central venous pressure ([@B36]). However, it is important to considerate that in anesthetized, mechanically ventilated patients, "physiological" values of ScvO~2~ are 5--10% higher (i.e., 75--80%) because of the decreased oxygen extraction of the brain. Second, when bleeding is present and blood loss is replaced by crystalloids, considerable hemodilution can take place. In our experimental stroke volume-guided hemorrhage and fluid resuscitation animal model, ScvO~2~ normalized at the end of resuscitation, but returned to a significantly lower level (with a mean of 5%) as the hemodilution caused significant drop in hemoglobin levels ([@B37]). In a clinical study performed on patients with esophagectomy, ScvO~2~ could indicate decreased DO~2~ caused by low hemoglobin levels; therefore, the authors suggest to use ScvO~2~ as complementary transfusion trigger to hemoglobin in the perioperative period ([@B32]).

High-risk patient with major surgery benefits most from goal-directed therapy with significant reduction in mortality and morbidity compared to patients with low-risk interventions ([@B38]). ScvO~2~ is an important element of this complex perioperative multimodal monitoring-based concept, including advanced hemodynamic monitoring and assessment of VO~2~/DO~2~, what we call the individualized, multimodal approach ([@B39]).

Complementary Blood Gas Parameters {#S5}
==================================

Venous-to-Arterial CO~2~ Gap (dCO~2~) {#S5-1}
-------------------------------------

Mixed-, or central venous-to-arterial carbon dioxide gap is an easily attainable parameter when patients has arterial and central venous lines *in situ*. The physiological value is ≤6 mmHg, and this holds true for both mixed- (Pv-aCO~2~) and central venous-to-arterial (Pcv-aCO~2~) CO~2~ gap values. Therefore, the central venous Pcv-aCO~2~-gap can be useful surrogate of Pv-aCO~2~ in the everyday practice.

Increased CO~2~ gap of \>40 mmHg was described 30 years ago during cardiac arrest in patients who were monitored with pulmonary artery catheters and also in an animal experiment on cardiopulmonary resuscitation ([@B40]). After these landmark studies, increased dCO~2~ was detected in several low-flow states ([@B41]--[@B43]). During anaerobic metabolism, increased production of hydrogen ions are buffered by bicarbonate presented in the cells, and this process will generate CO~2~ production ([@B44]). When the Fick principle is applied for carbon dioxide, there is an inverse relationship between the CO and dCO~2~ ([@B45]); in other words, increased levels of dCO~2~ should reflect low-flow states. Indeed, it has been shown that in sepsis, heart failure, and severe hypovolemia, its value can be elevated ([@B46], [@B47]).

In the perioperative setting, dCO~2~ also has a strong predictive value. Patients with high dCO~2~ had significantly higher mortality compared to patients with normal values (36.4 versus 4.5%) ([@B48]). High-risk surgical patients admitted to intensive care unit postoperatively with high dCO~2~ also developed more complications. The cutoff value was 5.8 mmHg ([@B49]), and in a different clinical study, a dCO~2~ \> 5 mmHg had 96% sensitivity to predict the occurrence of postoperative complications in patients with physiological (≥71%) ScvO~2~ ([@B50]). In critically ill patients, the dCO~2~ shows good inverse correlation with the CO ([@B42]), and it has also been shown to be a good predictor for bad outcome in patients with septic shock ([@B41]). In cases like septic shock, when due to microcirculatory or mitochondrial defects oxygen uptake is insufficient, ScvO~2~ can be supranormal. Previous studies have suggested that under such circumstances the increased value of dCO~2~ (\>5 mmHg) and increased lactate level can help the physician in detecting inadequate flow to the tissues; hence, the complementary use of ScvO~2~ and dCO~2~ is recommended ([@B50], [@B51]).

Conclusion {#S6}
==========

Early and adequate interventions to improve hemodynamics, oxygen delivery, and reducing oxygen needs have a significant effect on outcome. Protocolized care with predefined values of certain physiological indices, such as blood pressure, CO, may benefit the majority of the population, but these values may be inadequate for the rest; hence, they will remain either underresuscitated or overresuscitated. Therefore, individualizing treatment should be desirable. For this purpose, additional physiological parameters like central venous oxygen saturation, lactate, and venous-to-arterial CO~2~ gap should be assessed together with other hemodynamic variables to get a detailed picture about the hemodynamic status of our patients. Putting the pieces of the puzzle together in context is what we define as multimodal, individualized hemodynamic support, in which ScvO~2~ has a pivotal role.
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